In everyday life, when things turn out the opposite of what you expect, it’s usually cause for frustration. In science,…
Read More »therapies
A research team led by Prof. Julia Esser-von Bieren from the Center of Allergy and Environment (ZAUM) at Helmholtz Munich…
Read More »In 2021, a research team led by Prof. Heiko Lickert from Helmholtz Munich discovered the insulin-inhibitory receptor “Inceptor” and its…
Read More »A loss of brain volume associated with new immunotherapies for Alzheimer’s disease may be caused by the removal of amyloid…
Read More »Penn Engineers have cooked up a new way to improve mRNA delivery, developing an optimal “recipe” for ionizable lipids —…
Read More »Eradivir, a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads of advanced-stage influenza in…
Read More »The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent…
Read More »Researchers at the Centre for Genomic Regulation (CRG) reveal that metabolic enzymes known for their roles in energy production and…
Read More »Patients with late-stage cancer often have to endure multiple rounds of different types of treatment, which can cause unwanted side…
Read More »
He also tried levcromakalim, another blood vessel opener that lowers blood pressure. It’s a potassium-channel opener, and this, too, caused…
Read More »